About Us
Kinomica has developed KScan®, a phosphoproteomic
diagnostic platform to help better realize the full potential
of Precision Medicine.
We are a response-to-treatment company
focused on questions such as:
Of the drugs currently approved to treat a disease, which one is best for a particular patient?
For patients that don’t respond to treatment or relapse shortly afterwards, are there drugs approved for other diseases that may be beneficial?
How can phosphoproteomics help to
develop better drugs?
Importantly it provides insight on what proteins and signaling pathways are actually activated. Key information for developing next-generation diagnostics and for finding new drug targets.
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |